Significance of Improved Cytochemical Methods for Hemoprotein Enzymes in Diagnosis and Classification of Leukemia

  • Jacob S. Hanker
  • Peggy E. Yates
  • Wallace W. Ambrose
  • Joseph O. Moore
  • John Laszlo
  • William H. Starkweather
  • Beverly L. Giammara
Part of the Developments in Oncology Series book series (DION, volume 14)


Success in achieving remissions of acute myelogenous leukemia (AML) since the 1950s, and especially since the mid-1970s, has developed a need for greater attention on the part of physicians to improved methods for diagnosing and classifying the leukemias. The majority of AML patients can achieve first remissions, some (5–10%) lasting several years; these prolonged survivors are presumably cured of their leukemia. Many AML patients, however, are still not receiving the benefits of improved diagnostic methods and intensive therapeutic regimens. Of the latter group 80% are dead within a year of diagnosis [1].


Acute Myeloid Leukemia Acute Myelogenous Leukemia Azurophilic Granule Acute Myeloid Leukemia Patient Cytochemical Method 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Powles R, McElwain T. Introduction: Leukemia and lymphoma. Semin Hematol 19 (3) 153–154, 1982.PubMedGoogle Scholar
  2. 2.
    Lister TA, Rohatiner A7.S. The treatment of acute myelogenous leukemia in adults. Semin Hematol 19 (3): 172–192, 1982.PubMedGoogle Scholar
  3. 3.
    Hanker JS. Ambrose WW, James CJ. Mandelkorn J, Yates PE, Gall SA, Bossen EH, Fay JW, Laszlo J, Moore JO. Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia. Cancer Res. 39: 1635–1639. 1979.PubMedGoogle Scholar
  4. 4.
    de Salvo Cardullo L, Morilla R, Catovsky D. Significance ot phi bodies in acute leukemia. J Clin Pathol 34: 153–157, 1981.CrossRefGoogle Scholar
  5. 5.
    Catovsky D, de Salvo Cardullo L, O’Brien M, Morilla R. Costello C, Galton D, Ganeshaguru K, Hoffbrand V. Cytochemical markers of differentiation in acute leukemia. Cancer Res. 41 (11): 4824–4832, 1981.PubMedGoogle Scholar
  6. 6.
    Catovsky D. Crockard AD, Matutes E, O’Brien M. Cytochemistry of leukemic cells. In: Stoward PJ. Polak JM, eds. Histochemistry: The widening horizons of its applications in the biomedical sciences. Chichester, England: John Wiley & Sons, 1981, pp. 67–88.Google Scholar
  7. 7.
    Jansson S-E, Gripenberg J, Vuopio P, Teerenhovi I., Andersson LC. Classification of acutc leukaemia by light and electron microscope cytochemistrv. Scand J Haematol 25: 412–416, 1980.PubMedCrossRefGoogle Scholar
  8. 8.
    Tricot G, Broeckaert-van Orshoven A, Van Hoof A, Verwilghen RL. Sudan black B positivity in acute lymphoblastic leukaemia. Br J Haematol 51 (4): 615–621, 1982.PubMedCrossRefGoogle Scholar
  9. 9.
    Hanker JS, Romanovicz DK. Phi bodies: Peroxidase particles that produce crystal-loidal cellular inclusions. Science 197: 895–898, 1977.PubMedCrossRefGoogle Scholar
  10. 10.
    Youness E, Trujillo JM, Ahearn MJ, McCredie KB, Cork A. Acute unclassified leukemia: A clinicoparhologic study with 44 diagnostic implications of electron microscopy. Am J Hematol 9: 79–88, 1980.PubMedCrossRefGoogle Scholar
  11. 11.
    Reiffers J, Broustct A. Acutc myeloblasts leukemia masquerading as null-cell acute lymphoblastic leukemia. New Engl J Med 304: 1238–1239, 1981.PubMedGoogle Scholar
  12. 12.
    McCarty, Jr KS, Wortman J, Daly J, Rundies RW, Hanker JS. Chloroma (granulocytic sarcoma) without evidence of leukemia: Facilitated light microscopic diagnosis. Blood 56 (1): 104–108, 1980.PubMedGoogle Scholar
  13. 13.
    Hanker JS. Yates PE, Met?. CB, Rustioni A. A new specific, sensitive and noncar- cinogenic reagent for the demonstration of horseradish peroxidase. Histochcm J 9:789–792, I9?7.Google Scholar
  14. 14.
    Hanker JS, Giammara BL. Hemo-proteinopathy: molecular aggregation accompanying malignancy. Med Hypoth 7: 77–83, 1981.CrossRefGoogle Scholar
  15. 15.
    Hanker JS, Giammara BL. Hematology: Some advances and insights from histocytochemical and molecular biological studies of haemoproteins. In: Stoward PJ, Polak JM, eds. Histochemistry: The widening horizons of its applications in the biomedical sciences. Chichester, England: John Wiley & Sons. pp. 89–108. 1981.Google Scholar
  16. 16.
    Hanker JS, Laszlo J, Moore JO. The light microscopic demonstration of hydroperoxidasc-positive phi bodies and rods in leukocytes in acute myeloid leukemia. Histochemistry 58: 241–252, 1978.PubMedCrossRefGoogle Scholar
  17. 17.
    Carovsky D. Symposium: classification of leukemia: I. The classification of acute leukaemia. Pathology 14: 277–281, 1982.CrossRefGoogle Scholar
  18. 18.
    Bainton DF, Farquhar MG. Differences in enzyme Content of azurophil and specific granules of polymorphonuclear leukocytes: I. Histochemical staining of bone marrow smears. J Ceil Biol 39: 286–298. 1968.CrossRefGoogle Scholar
  19. 19.
    Graham RC Jr, Karnovsky MJ. The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: Ultrastructural cytochemistry by a new technique. J Histochem Cytochem 14: 291–302. 1966.PubMedCrossRefGoogle Scholar
  20. 20.
    Hanker JS, Ellis, LC, Jr, Rustioni A. Carson KA. Reiner A. Eldred W, Karten HJ. The ultrastructural demonstration of the retrograde axonal transport of horseradish peroxidase in nervous tissues by transmis¬sion and high voltage electron microscopy. In: Johnson JE, Jr ed. Current trends inc morphological research, vol. 1 Boca Raton. La.: CRC Press, 1981, pp. 55–91.Google Scholar
  21. 21.
    Tubbs RR, Sheibani K, Deodhar SD, Hawk WA. Enzyme immunohistochemistry: Review of technical aspects and diagnostic applications. Cleveland Clin Q 48 (2): 245–28l, 1981.Google Scholar
  22. 22.
    Sheibani K. Tubbs RR. Gephardt GN,.McMahon JT, Valenzuela R. Comparison of alternative chromogens for renal immunohistochemistry. Human Pathol 12: 349–354, 1981.CrossRefGoogle Scholar
  23. 23.
    Tubbs RR, Sheibani K. Chromogens for immunohistochemistry. Arch Pathol Lab Med 106 (4): 205, 1982.PubMedGoogle Scholar
  24. 24.
    Cabrillat H, Fontamiere B. Paraphenvl- enediamine-pyrocatechol: An alternative substrate to diaminobenzidine for the demonstration of endogenous peroxidase of mammalian leucocytes. Histochem J 12: 488–491, 1980.PubMedCrossRefGoogle Scholar
  25. 25.
    Sheibani K, Lucas FV. Tubbs RO. Savage RA, Hoeltge GA. Alternate chromogens as substitutes for benzidine for myeloperoxidase cytochemistry. Am J Clin Pathol 75: 367–370, 1981.PubMedGoogle Scholar
  26. 26.
    Lison L. Sur de nouveaux colorants histologiques spécifiques des lipides. C R Soc Biol 115: 202–205, 1934.Google Scholar
  27. 27.
    Lison L. Sur la recherche histochemique des oxydases par le reaction du bleu d’in-dophenol. Bull Soc Chim Biol 18: 185–189, 1936.Google Scholar
  28. 28.
    Ullie RD, Burtner HJ. Stable sudanophilia of human neutrophil leucocytes in relation to peroxidase and oxidase. J Histochem Cytochem 1: 8–25, 1953.CrossRefGoogle Scholar
  29. 29.
    Sheehan HL, Storey GW. An improved method of staining leukocyte granules with Sudan black B. J Pathol Bact 59 336. 1947.CrossRefGoogle Scholar
  30. 30.
    Mandelkorn J, Silverman MS, Harrison JE. Hanker JS. Immunofluorescent demonstration of myeloperoxidase of phi bodies and rods in leukaemic leucocytes. Histochem J 12: 449–456. 1980.PubMedCrossRefGoogle Scholar
  31. 31.
    Hanker JS. Chandross RJ. Solic JJ. Weath- erly NF, Laszlo J, Moore JO, Ottolenghi A. Medusa cells: Cytostructure and cyto¬chemistry of amoeboid eosinophils with pseudopod-like processes. Histochem J 13: 905–919. 1981.PubMedCrossRefGoogle Scholar
  32. 32.
    Hanker JS. Chandross RJ. Weatherly NF. Laszlo J. Moore JO. Buckley RH, Ottolenghi A. Medusa cells: The morphology and 3. cytochemistry of common amoeboid variations of eosinophils. Histochem J 12: 701–707, 1980.PubMedCrossRefGoogle Scholar
  33. 33.
    Hanker JS, Silverman MS, Romanovicz DK. Catalase in salivary gland striated and excretory duct cells: II. Ф body, an ellipsoidal peroxisomal organelle with crystalloid axial projections. Histochem J. 9: 7 29–744. 1977.Google Scholar
  34. 34.
    Yamada M, Mori M, Sugimura T. Purification and characterization of small molecular weight myeloperoxidase from human promyelocyte leukemia HL-60 cells. Biochemistry 20: 766–771, 1981.PubMedCrossRefGoogle Scholar
  35. 35.
    Stass SA. Holloway ML, Peterson V, Creegan WJ. Gallivan M, Schumacher 11R. Cytoplasmic fragments causing spurious platelet counts in the leukemic phase of poorly differentiated lymphocytic Ivmphoma. Am J Clin Pathol 71125–128, 1979-Google Scholar
  36. 36.
    Stass SA. Holloway ML, Slease RB. Schumacher HR. Spurious platelet counts in hairy cell leukemia. Am J Clin Pathol 68: 350–351, 1977.Google Scholar
  37. 37.
    Conjalka M, Rajdev N, Tavassoli M. Lymphoreticular fragments: The Cellular debris of acute lymphosarcoma cell leukemia. Cancer 44: 2124–2126. 1979.PubMedCrossRefGoogle Scholar
  38. 38.
    Armitage JO. Goeken JA, Feagler JR Spurious elevation of the platelet count in acute leukemia, J Am Med Assn 239: 433–434. 1978.CrossRefGoogle Scholar
  39. 39.
    Hanker JS, Giammara BL. Neutrophil pseudoplatelets: Their discrimination by myeloperoxidase demonstration. Science 220: 415–417, 1983.Google Scholar
  40. 40.
    Hanker JS. Ambrose WW. Yates PE.. Moore JO. Arnn ET, Giammara BL. Neutrophil pseudoplatelets: Elucidation and identification by myeloperoxidase demonstration. Submitted to Histochem J.Google Scholar
  41. 41.
    Breton-Gorius J, Reyes F, Duhamel G. Najman A, Gorin AC. Megakaryoblascic acute leukemia: Identification by the ultra- structural demonstration of platelet peroxidase. Blood 51: 45–60. 1978.PubMedGoogle Scholar
  42. 42.
    Edelson PJ. Cohn ZA. Peroxidasc- mediated mammalian cell cytotoxicity. J Exp Med 138:318–323, 197 3.Google Scholar
  43. 43.
    Clark RA, Klebanoff SJ. Neutrophil- mediated tumor cell toxicity: Role of the peroxidase system. J Exp Med 141: 1442–1447, 1975.PubMedCrossRefGoogle Scholar
  44. 44.
    Clark RA. Szot R The myeloperoxidase- hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity..J Immunol 126: 1295–1301. 1981.PubMedGoogle Scholar
  45. 45.
    Clark RA, Olsson I, Klebanoff SJ Cytotoxicity for tumor cells of canonic proteins from human neutrophil granules. J Cell Biol 70: 719–723, 1976.PubMedCrossRefGoogle Scholar
  46. 46.
    Nathan C. Cohn Z. Role of oxygen-dependent mechanisms in antibody-induced lysis of tumor cells by activated macrophages. J Exp Med 152: 198–208. 1980.PubMedCrossRefGoogle Scholar
  47. 47.
    Maldonado JF. The ultrastructure of the platelets in refractory anemia (“preleukemia”) and myelomonocytic leukemia. Ser Hematol 8: 101–125. 1975.Google Scholar
  48. 48.
    Maldonado JE. Platelet granulopathy. A new morphologic feature in preleukemia and myelomonocytic leukemia: Light microscopy and ultrastruaural morphology and cytochemistry. Mayo Clin Proc 51: 452–462. 1976.Google Scholar
  49. 49.
    Lichtman MA. Cellular deformability dur¬ing maturation of the myeloblast: Possible- role in marrow egress. New Engl J Med 283: 943–948. 1970.PubMedCrossRefGoogle Scholar
  50. 50.
    Merz, B. Newly identified particle may explain spuriously elevated platelet count. J Am Med Assn 239: 3146–5147, 1983.Google Scholar
  51. 51.
    Gill GW. Frost JK, Miller KA. A new formula for a half-oxidized hematoxylin solution that neither overstains nor requires differentiation. Acta Cytol 18: 300–311. 1974.Google Scholar
  52. 52.
    Yam LT. Li CY. Crosby WH. Cytochem- ical identification of monocytes and granulocytes. Am J Clin Path 55: 28 3–290. 1971.Google Scholar
  53. 53.
    Berman EL, Carter HW. Ambrose WW. Hanker JS. Studies of eosinophil medusa cells by electron imaging modes. Scanning Electron Microscopy pp. 311–321, 1983.Google Scholar
  54. 54.
    Sigma Technical Bulletin no. 390. Sigma Chemical Co., P.O. Box 14508. St. Louis. MO 63178.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston/The Hague/Dordrecht/Lancaster 1984

Authors and Affiliations

  • Jacob S. Hanker
  • Peggy E. Yates
  • Wallace W. Ambrose
  • Joseph O. Moore
  • John Laszlo
  • William H. Starkweather
  • Beverly L. Giammara

There are no affiliations available

Personalised recommendations